Princeton, N.J. – As First Responders across the nation train and prepare to respond to potential terrorist attacks, they can now add an effective decontamination tool against Chemical Warfare (CW) agents and T2 toxin to the protective equipment they wear and carry when responding to emergencies.
RSDecon, a business of Bracco Diagnostics, Inc., offers a proven, safe, fast-acting and easy-to-use form of protection against all known CW agents with its RSDL product.
RSDL is a broad-spectrum liquid CW agent decontaminant that removes and neutralizes CW agents and T2 toxin from skin within two minutes. In the past, RSDL could only be purchased and deployed by military organizations, but it is now available to First Responders such as fire departments, law enforcement agencies, emergency medical services and healthcare facilities worldwide.
The lotion is standard equipment carried by head-of-state protection agencies in both the U. S. and 
abroad, as well as major U. S. police and fire departments, including the New York City Fire Department (FDNY). It has been formally tested and proven effective by both the Department of Defense (DoD) and multiple NATO military organizations, and is deployed by troops in Iraq and Afghanistan. It has been demonstrated to be safe and effective as a skin decontaminate and has been cleared by the U. S. Food and Drug Administration (FDA).
In addition to helping neutralize CW agents and T2 toxin on First Responders’ gear and skin, it also helps ensure they can return to their duties quickly when they are needed most: in the first phase of an incident or attack. Unlike water or powder-based technologies, which can smear or spread the CW agent, RSDL decontaminates or removes the contaminant from the skin.
About RSDL RSDL is a patented, broad spectrum topical skin decontamination product intended to remove or neutralize CW agents or T2 toxin from the skin. RSDL is manufactured by E-Z-EM Inc. in Lake Success, NY. Originally developed for the Canadian Ministry of Defense, RSDL has since been adopted by several military services around the world. The U. S. FDA issued 510(k) clearance for RSDL in March of 2003. The U. S. FDA has cleared the use of RSDL in 21 and 42 mL packets.
Important Safety Information: For external use only. Contact with eyes and mucous membranes should be avoided. In emergency conditions, RSDL does not require immediate removal from the skin and can be left on under protective clothing, but should be rinsed as soon as it is safe to do so. An ingredient of RSDL is absorbed. Studies with RSDL left on the skin for 24 hours showed minimal adverse effects. Studies beyond this point have not been conducted. Avoid prolonged skin contact.
About RSDecon RSDecon is a business unit of Bracco Diagnostics Inc. To learn more about RSDL, visit www.RSDecon.com, call 1-888-RSDecon (1-888-773-3266), or contact Rosemarie Vertullo, Senior Sales Director for North America, at rosemarie.vertullo@diag.bracco.com.
For more information, contact: Jeff Jordan RSDecon Phone: 609-514-2258 Email: jeff.jordan@diag.bracco.com
Emily Dell Stern + Associates Phone: 908-276-4344 x210 Email: emily@sternassociates.com
Tom Healey Stern + Associates Phone: 908-276-4344 x224 Email: tom@sternassociates.com